Molecular phenotypes of matched in situ and invasive components of breast carcinomas

Human Pathology

Volumn 42, Issue 10, 2011, Pages 1438-1446

  Martins, Diana ^a   Sousa, Bárbara ^a   Lopes, Nair ^a   Gomes, Madalena ^a   Veronese, Luiz ^b   Albergaria, André ^a   Paredes, Joana ^a   Schmitt, Fernando ^a,c  

^a UNIVERSITY OF PORTO   (Portugal)

^b Department of Pathology   (Brazil)

^c University of Porto   (Portugal)

Author keywords

In situ breast carcinoma; Invasive breast carcinoma; Molecular profile; Tissue microarray

Indexed keywords

CYTOKERATIN 5; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; GAMMA UROGASTRONE; KI 67 ANTIGEN; P CADHERIN; PROGESTERONE RECEPTOR;

ARTICLE; BREAST CANCER; BREAST CARCINOMA; CANCER CLASSIFICATION; CANCER IMMUNOLOGY; CARCINOMA IN SITU; CELL PROLIFERATION; CONTROLLED STUDY; GENE OVEREXPRESSION; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; INVASIVE CARCINOMA; LUMINAL A BREAST CANCER; LUMINAL B BREAST CANCER; LYMPH NODE METASTASIS; PHENOTYPE; PROTEIN EXPRESSION; TISSUE MICROARRAY; TUMOR VOLUME;

BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM INVASIVENESS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 80053182840     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2010.08.024     Document Type: Article

References (33)

1. A. Ghafoor, A. Jemal, E. Ward, V. Cokkinies, R. Smith, and M. Thun Trends in breast cancer by race and ethnicity CA Cancer J Clin 53 2003 342 355 (Pubitemid 38081592)
2. S.R. Kakhani The transition from hyperplasia to invasive carcinoma of the breast J Pathol 187 1999 272 278
3. M. Hu, J. Yao, and D.K. Carroll Regulation of in situ to invasive breast carcinoma transition Cancer Cell 13 2008 394 406 (Pubitemid 351609443)
4. H.J. Burstein, K. Polyak, J.S. Wong, S.C. Lester, and C.M. Kaelin Ductal carcinoma in situ of the breast N Engl J Med 350 2004 1430 1441 (Pubitemid 38419997)
5. W.D. Dupont, F.F. Parl, and W.H. Hartmann Breast cancer risk associated with proliferative breast disease and atypical hyperplasia Cancer 71 1993 1258 1265 (Pubitemid 23054916)
6. C.L. Carter, D.K. Corle, M.S. Micozzi, A. Schatzkin, and P.R. Taylor A prospective study of the development of breast cancer in 16,692 women with benign breast disease Am J Epidemiol 128 1988 467 477
7. S.R. Lakhani, R. Chaggar, and S. Davies Genetic alterations in "normal" luminal and myoepithelial cells of the breast J Pathol 189 1999 496 503
8. P. O'Connell, V. Pekkel, S.A. Fuqua, C.K. Osborne, G.M. Clark, and D.C. Allred Analysis of loss of heterozygosity in 399 pre-malignant breast lesions at 15 genetic loci J Natl Cancer Inst 90 1998 697 703 (Pubitemid 28222144)
9. E.S. Hwang, S. DeVries, and K.L. Chew Patterns of chromosomal alterations in breast ductal carcinoma in situ Clin Cancer Res 10 2004 5160 5167 (Pubitemid 39099791)
10. H. Buerger, R. Simon, and K.L. Schafer Genetic relation of lobular carcinoma in situ, ductal carcinoma in situ, and associated invasive carcinoma of the breast Mol Pathol 53 2000 118 121 (Pubitemid 30396450)
11. J.F. Simpson, D.E. Quan, F. O'Malley, T. Odom-Maryon, and P.E. Clarke Amplification of CCND1 and expression of its protein product, cyclin D1, in ductal carcinoma in situ of the breast Am J Pathol 151 1997 161 168 (Pubitemid 27283968)
12. L. Wiechman, and H.M. Kuerer The molecular journey from ductal carcinoma in situ to invasive breast cancer Cancer 112 2008 2130 2142 (Pubitemid 351628621)
13. C.A. Bodian, K.H. Perzin, R. Lattes, and P. Hoffmam Reproducibility and validity of pathologic classification of benign breast disease and implications for clinical applications Cancer 71 1993 3908 3913 (Pubitemid 23172968)
14. J. Hannemann, A. Velds, J.B. Halfwerk, B. Kreike, J.L. Peterse, and M.J. Vijver Classification of ductal carcinoma in situ by gene expression profiling Breast Cancer Res 8 2006 R61
15. G.S. Dalgin, G. Alexe, and D. Scanfield Portraits of breast cancer progression BCM Bioinformatics 6 2007 8 291
16. T.O. Nielsen, F.D. Hsu, and K. Jensen Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma Clin Cancer Res 10 2004 5367 5374 (Pubitemid 39100473)
17. I. Matos, R. Dufloth, M. Alvarenga, L.C. Zeferino, and F. Schmitt P63, cytokeratin 5 and P-cadherin: three molecular markers to distinguish basal phenotype in breast carcinomas Virchows Arch 447 2005 688 694 (Pubitemid 41571183)
18. J. Paredes, N. Lopes, F. Milanezi, and F. Schmitt P-cadherin and cytokeratin 5: useful adjunct markers to distinguish basal-like ductal carcinomas in situ Virchows Arch 450 2007 73 80 (Pubitemid 46360747)
19. C. Leal, F.C. Schmitt, M.J. Bento, N. Maia, and C. Lopes Ductal carcinoma in situ of the breast: histological categorization and its relationship to ploidy and immunohistochemical expression of hormone receptors, p53 and c-erbB-2 protein Cancer 75 1995 2123 2131
20. C.W. Elston, and I.O. Ellis Pathological prognostic factors in breast cancer I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up Histopathology 19 1991 403 410
21. S. Bacus, J.L. Flowers, M.F. Press, J.W. Bacus, and K.S. McCarty Jr The evaluation of oestrogen receptor in primary breast carcinoma by computer-assisted image analysis Am J Clin Pathol 90 1988 233 239
22. S. Badve, and H. Nakshatri Oestrogen receptor-positive breast cancer: towards bridging histopathologic and molecular classifications J Clin Pathol 62 2009 6 12
23. M.C. Chang, S.K. Chia, and D. Voduc Ki67 Index, HER2 status, and prognosis of patients with luminal B breast cancer J Natl Cancer Inst 101 2009 736 750
24. J.S. Reis-Filho, F. Milanezi, and S. Carvalho Metaplastic breast carcinomas exhibit EGFR, but not HER2, gene amplification and overexpression: immunohistochemical and chromogenic in situ hybridization analysis Breast Cancer Res 7 2005 R1028 R1035
25. S.K. Grupta, A.G. Douglas-Jones, N. Fenn, J.M. Morgan, and R.E. Mansel The clinical behavior of breast carcinoma is probably determined at the preinvasive stage (ductal carcinoma in situ) Cancer 80 1997 1740 1745 (Pubitemid 27475931)
26. D. Porter, J. Lahti-Domenici, and A. Keshaviah. Molecular markers in ductal carcinoma in situ of the breast Mol Cancer Res 1 2003 362 375 (Pubitemid 36437922)
27. S. Nofech-Mozes, J. Spayne, E. Rakovich, and W. Hanna Prognostic and predictive molecular markers in DCIS: a review Adv Anat Pathol 12 2005 256 264 (Pubitemid 41463806)
28. E.C. Mommers, A.M. Leonhart, and F. Falix Similarity in expression of cell cycle proteins between in situ and invasive ductal breast lesions of same differentiation grade J Pathol 194 2001 327 333 (Pubitemid 32624559)
29. R.M. Tamimi, H.J. Baer, and J. Marotti Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer Breast Cancer Res 10 2008 R67
30. M.R. Hussein, S.R. Abd-Elwahed, and A.R. Abdulwahed Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast Cell Biol Int 32 2008 698 707
31. N.P. Castro, C.A.B.T. Osório, and C. Torres Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma Breast Cancer Res 10 2008 R87
32. S.T. Schnitt The transition from ductal carcinoma in situ to invasive breast cancer: the other side of the coin Breast Cancer Res 11 2009 101
33. S.T. Schnitt Molecular biology of breast tumor progression: a view from the other side Int J Surg Pathol 18 2010 170S 173S